SCHEMBL9817660

SCHEMBL9817660

CCOC(=O)Cc1ccc(C#Cc2cc3c(cc2CC)SCCC3(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ RARA P10276 11/20 0.49
▸ RARB P10826 11/20 0.49
▸ RARG P13631 11/20 0.49
▸ CYP3A4 P08684 3/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ FDFT1 P37268 1/20 0.41
▸ CYP26A1 O43174 2/20 0.40
▸ CYP4Z1 Q86W10 1/20 0.35
▸ ACACB O00763 3/20 0.35
▸ RXRA P19793 2/20 0.35
▸ CRABP2 P29373 1/20 0.33
▸ FFAR1 O14842 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9817691 0.93 RARA (0.47) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817713 0.92 RARA (0.49) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817700 0.92 RARB (0.46) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817639 0.91 RARB (0.45) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817852 0.90 RARB (0.45) RARARARBRARGCYP3A4KMT2A
SCHEMBL8672295 0.89 FDFT1 (0.40) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817836 0.87 RARB (0.61) RARARARBRARGCYP3A4KMT2A
SCHEMBL8674063 0.82 FDFT1 (0.40) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817703 0.82 CYP26A1 (0.40) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817823 0.81 RARB (0.47) RARARARBRARGCYP3A4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0290130-B1 ACETYLENES DISUBSTITUTED WITH A PHENYL GROUP AND A HETEROBICYCLIC GROUP HAVING RETINOID LIKE ACTIVITY ALLERGAN, INC (US) 1991-11-06 — — EP disclosed
US-4810804-A PSORIASIS ALLERGAN, INC. (US) 1989-03-07 — — US disclosed
EP-0290130-A1 Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid like activity ALLERGAN, INC (US) 1988-11-09 — — EP disclosed
Send feedback